SY 161-P5
Alternative Names: PEG-Sak; PEG-SakSTAR; PEG-staphylokinase; PEGylated recombinant staphylokinase variantLatest Information Update: 11 Sep 2018
At a glance
- Originator University of Leuven
- Class Plasminogen activator enzymes; Recombinant proteins; Thrombolytics
- Mechanism of Action Plasminogen activators
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Discontinued Myocardial infarction
Most Recent Events
- 10 Sep 2018 Thrombogenics is now called Oxurion
- 14 Dec 2006 Discontinued - Phase-II for Myocardial infarction in Europe (IV)
- 14 Dec 2006 Discontinued - Phase-II for Myocardial infarction in USA (IV)